Adipocyte
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q3 | 50.5% | 0.974 | Q1 | 83.2% |
| 2024 | 3.1 | Q2 | 54.9% | 1.084 | Q1 | 86.2% |
| 2023 | 3.5 | Q2 | 63.1% | 0.960 | Q1 | 84.5% |
| 2022 | 3.3 | Q3 | 49.2% | 0.913 | Q2 | 84.1% |
| 2021 | 3.6 | Q3 | 50.8% | 0.682 | Q2 | 76.7% |
| 2020 | — | — | 0.865 | Q2 | 81.9% | |
| 2019 | — | — | 1.157 | Q1 | 88.6% | |
| 2018 | — | — | 0.754 | Q2 | 77.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2162-397X
ISSN
2162-3945
region
Western Europe
coverage
2013-2026